Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Loft H
383  Ergebnisse:
Personensuche X
?
1

Treatment effects on residual cognitive symptoms among part..:

Nierenberg, A.A. ; Loft, H. ; Olsen, C.K.
Journal of Affective Disorders.  250 (2019)  - p. 35-42 , 2019
Link: https://doi.org/10.1016/..
 
?
2

PMH27 SUCCESSFULLY TREATED PATIENTS WITH VORTIOXETINE VERSU..:

Wang, G. ; Zhao, K. ; Reynaud-Mougin, C....
Value in Health.  22 (2019)  - p. S685 , 2019
Link: https://doi.org/10.1016/..
 
?
3

Effects of vortioxetine on composite scores across objectiv..:

Loft, H. ; Jacobson, W. ; Olsen, C.K.
European Neuropsychopharmacology.  27 (2017)  - p. S797-S798 , 2017
Link: https://doi.org/10.1016/..
 
?
4

The Effects of Vortioxetine on Cognitive Function in Patien..:

McIntyre, RS ; Harrison, J ; Loft, H..
International Journal of Neuropsychopharmacology.  19 (2016)  10 - p. pyw055 , 2016
Link: https://doi.org/10.1093/..
 
?
5

P.2.f.005 Vortioxetine effects on overall patient functioni..:

Florea, I. ; Loft, H. ; Danchenko, N....
European Neuropsychopharmacology.  25 (2015)  - p. S436 , 2015
Link: https://doi.org/10.1016/..
 
?
6

P.2.h.011 Meta-analysis of cognitive function in vortioxeti..:

McIntyre, R. ; Harrison, J. ; Loft, H...
European Neuropsychopharmacology.  25 (2015)  - p. S459-S460 , 2015
Link: https://doi.org/10.1016/..
 
?
7

P.2.h.009 Maintenance of vortioxetine efficacy with long-te..:

Vieta, E. ; Loft, H. ; Florea, I.
European Neuropsychopharmacology.  25 (2015)  - p. S458-S459 , 2015
Link: https://doi.org/10.1016/..
 
?
8

P.2.h.008 Effectiveness of long-term vortioxetine treatment..:

Vieta, E. ; Loft, H. ; Florea, I.
European Neuropsychopharmacology.  25 (2015)  - p. S458 , 2015
Link: https://doi.org/10.1016/..
 
?
9

P.2.f.020 The efficacy of vortioxetine in treating patients..:

Baldwin, D.S. ; Loft, H. ; Jacobsen, P.L..
European Neuropsychopharmacology.  24 (2014)  - p. S463-S464 , 2014
Link: https://doi.org/10.1016/..
 
?
10

P.2.f.023 The efficacy of vortioxetine in the treatment of ..:

Vieta, E. ; Loft, H. ; Mahableshwarkar, A.R..
European Neuropsychopharmacology.  24 (2014)  - p. S465-S466 , 2014
Link: https://doi.org/10.1016/..
 
?
11

The effect of vortioxetine (LU AA21004) on health-related q..:

Florea, I. ; Danchenko, N. ; Loft, H....
Value in Health.  16 (2013)  3 - p. A65 , 2013
Link: https://doi.org/10.1016/..
 
?
12

P.2.c.010 The multimodal antidepressant Lu AA21004: open-la..:

Florea, I. ; Dragheim, M. ; Loft, H.
European Neuropsychopharmacology.  22 (2012)  - p. S255-S256 , 2012
Link: https://doi.org/10.1016/..
 
?
13

P.4.a.003 Prevention of relapse in adult patients with gene..:

Baldwin, D.S. ; Loft, H. ; Florea, I.
European Neuropsychopharmacology.  22 (2012)  - p. S358-S359 , 2012
Link: https://doi.org/10.1016/..
 
?
14

P.2.c.024 A double-blind, randomised, placebocontrolled, re..:

Dragheim, M. ; Loft, H. ; Florea, I..
European Neuropsychopharmacology.  21 (2011)  - p. S396-S397 , 2011
Link: https://doi.org/10.1016/..
 
?
15

P.2.c.013 A randomised, double-blind, placebo controlled, d..:

Baldwin, D. ; Loft, H. ; Dragheim, M.
European Neuropsychopharmacology.  21 (2011)  - p. S390 , 2011
Link: https://doi.org/10.1016/..
 
1-15